Psychosis in patients with narcolepsy as an adverse effect of sodium oxybate

Frontiers in Neurology

Volumn 5 JUL, Issue , 2014, Pages 136-

  Sarkanen, Tomi ^a,b   Niemelä, Valter ^c   Landtblom, Anne Marie ^c,d   Partinen, Markku ^b,e  

^a Central Finland Central Hospital   (Finland)

^b Vitalmed Research Centre   (Finland)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^d LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^e UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Gamma hydroxybutyrate; Hallucinations; Narcolepsy; Psychosis; Schizophrenia; Sleep disorders; Sodium oxybate; Xyrem

Indexed keywords

AMPHETAMINE; CYCLOSPORIN; INFLUENZA VACCINE; METHYLPHENIDATE; MODAFINIL; OLANZAPINE; OREXIN; OXYBATE SODIUM; RISPERIDONE; SERTRALINE; TRAMADOL;

ADOLESCENT; ADULT; ANXIETY DISORDER; ARTHRITIS; ARTICLE; AUDITORY HALLUCINATION; CASE REPORT; CATAPLEXY; DAYTIME SOMNOLENCE; DEPRESSION; DISEASE CLASSIFICATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EVENING DOSAGE; FEMALE; HUMAN; HYPNAGOGIC HALLUCINATION; HYPNOPOMPIC HALLUCINATION; IMMUNOMODULATION; INFLUENZA A (H1N1); MALE; NARCOLEPSY; NECK PAIN; NUCLEUS ACCUMBENS; OBESITY; PARASOMNIA; PATHOGENESIS; PHENOMENOLOGY; PROTEIN ANALYSIS; PROTEIN FUNCTION; PSYCHOSIS; SCHIZOPHRENIA; UNSPECIFIED SIDE EFFECT; VENTRAL TEGMENTUM; YOUNG ADULT;

EID: 84904433776     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2014.00136     Document Type: Article

References (31)

1. Yoss RE, Daly DD. Narcolepsy. Archives of internal medicine. 1960 Aug;106:168-71. PubMed PMID: 13855452. Epub 1960/08/01. eng.
2. Young D, Scoville W. Paranoid psychosis in narcolepsy and the possible danger of benzedrine treatment. The Medical Clinics of North America. 1938 (22):637-46.
3. Brown D. A case of narcolepsy. Journal of Mental Science. 1908 (54]:107-12.
4. Roy A. Psychiatric aspects of narcolepsy. The British journal of psychiatry: the journal of mental science. 1976 Jun;128:562-5. PubMed PMID: 1276566. Epub 1976/06/01. eng.
5. Huang YS, Guilleminault C, Chen CH, Lai PC, Hwang FM. Narcolepsy-cataplexy and schizophrenia in adolescents. Sleep medicine. 2014 Jan;15(l]:15-22. PubMed PMID: 24268496.
6. Kishi Y, Konishi S, Koizumi S, Kudo Y, Kurosawa H, Kathol RG. Schizophrenia and narcolepsy: A review with a case report. Psychiatry and Clinical Neurosciences. 2004;58(2]:117-24.
7. Peyron C, Faraco J, Rogers W, Ripley B, Overeem S, Charnay Y, et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med. 2000 Sep;6(9]:991-7. PubMed PMID: 10973318. Epub 2000/09/06.
8. Lambe EK, Liu RJ, Aghajanian GK. Schizophrenia, hypocretin (orexin], and the thalamocortical activating system. Schizophrenia bulletin. 2007 Nov;33(6]:1284-90. PubMed PMID: 17656637. Pubmed Central PMCID: PMC2779889. Epub 2007/07/28. eng.
9. Korotkova TM, Sergeeva OA, Eriksson KS, Haas HL, Brown RE. Excitation of ventral tegmental area dopaminergic and nondopaminergic neurons by orexins/hypocretins. The Journal of neuroscience: the official journal of the Society for Neuroscience. 2003 Jan 1;23(1]:7-11. PubMed PMID: 12514194. Epub 2003/01/07. eng.
10. Pizza F, Magnani M, Indrio C, Plazzi G. The Hypocretin System and Psychiatric Disorders. Curr Psychiatry Rep. 2013 2013/12/24;16(2]:l-10. English.
11. Partinen M, Kornum BR, Plazzi G, Jennum P, Julkunen I, Vaarala O. Narcolepsy as an autoimmune disease: the role of H1N1 infection and vaccination. Lancet Neurol. 2014 Jun;13(6]:600-13. PubMed PMID: 24849861. Epub 2014/05/23. Eng.
12. De la Herran-Arita AK, Kornum BR, Mahlios J, Jiang W, Lin L, Hou T, et al. CD4+ T Cell Autoimmunity to Hypocretin/Orexin and Cross-Reactivity to a 2009 H1N1 Influenza A Epitope in Narcolepsy. Sci Transl Med. 2013 Dec 18;5(216]:216ral76. PubMed PMID: 24353159. Epub 2013/12/20.
13. Tsutsui K, Kanbayashi T, Tanaka K, Boku S, Ito W, Tokunaga J, et al. Anti-NMDAreceptor antibody detected in encephalitis, schizophrenia, and narcolepsy with psychotic features. BMC Psychiatry. 2012;12:37. PubMed PMID: 22569157. Pubmed Central PMCID: PMC3436772. Epub 2012/05/10. eng.
14. Knudsen S, Biering-Sorensen B Fau-Kornum BR, Kornum Br Fau-Petersen ER, Petersen Er Fau-Ibsen JD, Ibsen Jd Fau-Gammeltoft S, Gammeltoft S Fau-Mignot E, et al. Early IVIg treatment has no effect on post-HlNl narcolepsy phenotype or hypocretin deficiency. 2012 20120703 DCOM- 20120917;Neurology(1526-632X (Electronic]], eng.
15. Kodavali CV, Watson AM, Prasad KM, Celik C, Mansour H, Yolken RH, et al. HLA associations in schizophrenia: are we re-discovering the wheel? American journal of medical genetics Part B, Neuropsychiatric genetics: the official publication of the International Society of Psychiatric Genetics. 2014 Jan;165(l]:19-27. PubMed PMID: 24142843. Epub 2013/10/22. eng.
16. Fortuyn HA, Lappenschaar GA, Nienhuis FJ, Furer JW, Hodiamont PP, Rijnders CA, et al. Psychotic symptoms in narcolepsy: phenomenology and a comparison with schizophrenia. General hospital psychiatry. 2009 Mar-Apr;31(2]:146-54. PubMed PMID: 19269535. Epub 2009/03/10.
17. Yoon JH, Minzenberg MJ, Raouf S, D'Esposito M, Carter CS. Impaired prefrontalbasal ganglia functional connectivity and substantia nigra hyperactivity in schizophrenia. Biol Psychiatry. 2013 Jul 15;74(2]:122-9. PubMed PMID: 23290498. Pubmed Central PMCID: PMC3620727. Epub 2013/01/08. eng.
18. Davis KL, Kahn RS, Ko G, Davidson M. Dopamine in schizophrenia: a review and reconceptualization. The American journal of psychiatry. 1991 Nov;148(ll]:1474-86. PubMed PMID: 1681750. Epub 1991/11/01. eng.
19. Ohayon MM. Narcolepsy is complicated by high medical and psychiatric comorbidities: a comparison with the general population. Sleep medicine. 2013 Jun;14(6]:488-92. PubMed PMID: 23643648. Epub 2013/05/07.
20. Group USXMS. A 12-month, open-label, multicenter extension trial of orally administered sodium oxybate for the treatment of narcolepsy. Sleep. 2003 Feb l;26(l]:31-5. PubMed PMID: 12627729. Epub 2003/03/12. eng.
21. Xyrem® International Study G. Further evidence supporting the use of sodium oxybate for the treatment of cataplexy: a double-blind, placebo-controlled study in 228 patients. Sleep medicine. 2005 9//;6(5]:415-21.
22. Lecendreux M, Poli F, Oudiette D, Benazzouz F, Donjacour CE, Franceschini C, et al. Tolerance and efficacy of sodium oxybate in childhood narcolepsy with cataplexy: a retrospective study. Sleep. 2012 May;35(5]:709-ll. PubMed PMID: 22547897. Pubmed Central PMCID: 3321430. Epub 2012/05/02.
23. Partinen M, Saarenpaa-Heikkila O, Ilveskoski I, Hublin C, Linna M, Olsen P, et al. Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland. PloS one. 2012;7(3]:e33723. PubMed PMID: 22470463. Pubmed Central PMCID: 3314680. Epub 2012/04/04.
24. Chien J, Ostermann G, Turkel SB. Sodium oxybate-induced psychosis and suicide attempt in an 18-year-old girl. Journal of child and adolescent psychopharmacology. 2013 May;23(4]:300-l. PubMed PMID: 23647134. Epub 2013/05/08. eng.
25. Langford J, Gross WL. Psychosis in the context of sodium oxybate therapy. Journal of clinical sleep medicine: JCSM: official publication of the American Academy of Sleep Medicine. 2011 Dec 15;7(6]:665-6. PubMed PMID: 22171207. Pubmed Central PMCID: PMC3227714. Epub 2011/12/16. eng.
26. Ortega-Albas JJ, Lopez-Bernabe R, Garcia AL, Gomez JR. Suicidal ideation secondary to sodium oxybate. The Journal of neuropsychiatry and clinical neurosciences. 2010 Summer;22(3]:352r e26- e26. PubMed PMID: 20686162. Epub 2010/08/06. eng.
27. Benarroch EE. Gamma-hydroxybutyric acid and its relevance in neurology. Neurology. 2009 Jan 20;72(3]:282-6. PubMed PMID: 19153376. Epub 2009/01/21. eng.
28. Black J, Pardi D, Hornfeldt CS, Inhaber N. The Nightly Use of Sodium Oxybate Is Associated with a Reduction in Nocturnal Sleep Disruption: A Double-Blind, Placebo-Controlled Study in Patients with Narcolepsy. Journal of Clinical Sleep Medicine. 2010 Dec 15;6(6]:596-602. PubMed PMID: WOS:000285532900011. English.
29. Cruz HG, Ivanova T, Lunn ML, Stoffel M, Slesinger PA, Luscher C. Bi-directional effects of GABA(B] receptor agonists on the mesolimbic dopamine system. Nature neuroscience. 2004 Feb;7(2]:153-9. PubMed PMID: 14745451. Epub 2004/01/28. eng.
30. Komossa K, Rummel-Kluge C, Schmid F, Hunger H, Schwarz S, El-Sayeh HG, et al. Aripiprazole versus other atypical antipsychotics for schizophrenia. The Cochrane database of systematic reviews. 2009 (4]:CD006569. PubMed PMID: 19821375. Epub 2009/10/13. eng.
31. Naber D, Lambert M. Aripiprazole: a new atypical antipsychotic with a different pharmacological mechanism. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2004 12//;28(8]:1213-9.